The Very Favorable Metastatic Renal Cell Carcinoma (Mrcc) Risk Group: Data From The International Metastatic Rcc Database Consortium (Imdc).

339Background: The IMDC criteria have been used as a prognostic tool for patients with mRCC receiving single agent VEGF-targeted drugs, and more recently combination immuno-oncology (IO) +/- VEGF-t...